Thomas F. Bodley MD, MSc , Dominique Piquette MD, PhD , Kaveh G. Shojania MD , Ruxandra Pinto PhD , Damon C. Scales MD, PhD , Andre C.K.B. Amaral MD
{"title":"Barriers, Facilitators, and Trends in Prone Positioning for ARDS","authors":"Thomas F. Bodley MD, MSc , Dominique Piquette MD, PhD , Kaveh G. Shojania MD , Ruxandra Pinto PhD , Damon C. Scales MD, PhD , Andre C.K.B. Amaral MD","doi":"10.1016/j.chstcc.2024.100059","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Prone positioning is a historically underused evidence-based practice for ARDS. Despite increased prone positioning during the COVID-19 pandemic, some patients may remain at risk of nonuse.</p></div><div><h3>Research Question</h3><p>What is the current evidence-based gap for prone positioning in ARDS, how is use changing over time, and what are patient-level barriers and facilitators to prone positioning?</p></div><div><h3>Study Design and Methods</h3><p>This retrospective cohort included invasively ventilated adults with ARDS and who met prone positioning criteria from six hospitals. The rate of prone positioning among eligible patients was summarized from January 2018 through December 2021. Segmented Poisson regression was used to describe temporal trends. Logistic regression was used to identify patient-level barriers and facilitators to prone positioning.</p></div><div><h3>Results</h3><p>Seven hundred ninety-nine patients fulfilled criteria for prone positioning. The mean age was 57 years, 125 patients (15.6%) had COVID-19, mean ICU stay was 19.5 days, and the mortality rate was 50.1%. Prone positioning was used in 297 of 799 patients (37.2%). Prone positioning was increasing before the pandemic with a relative rate (RR) of 1.12 per quarter (95% CI, 1.03-1.22). Prone positioning increased during the pandemic vs before the pandemic (RR, 1.62; 95% CI, 1.02-2.61), but not for patients with nonrespiratory diagnoses causing ARDS (RR, 0.74; 95% CI, 0.22-2.52). Barriers to prone positioning included vasopressor use (OR for withholding prone positioning, 1.15 per 0.1 μm/kg/min norepinephrine equivalent; 95% CI, 1.06-1.26), age (OR, 1.12 per 5 years; 95% CI, 1.03-1.22), and having undergone surgery (OR, 2.41; 95% CI, 1.00-5.81). Facilitators included having COVID-19 (OR for withholding prone positioning, 0.10; 95% CI, 0.04-0.24) or another respiratory illness (OR, 0.42; 95% CI, 0.23-0.79), and receiving neuromuscular blockade (OR, 0.22; 95% CI, 0.13-0.38).</p></div><div><h3>Interpretation</h3><p>Despite increased prone positioning during the COVID-19 pandemic, an evidence-based gap persists, especially for patients with nonrespiratory causes of ARDS. Multiple barriers and facilitators must be targeted to increase prone positioning.</p></div>","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":"2 2","pages":"Article 100059"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949788424000133/pdfft?md5=76fd29a6380dd3123a2b912a03a6f74c&pid=1-s2.0-S2949788424000133-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788424000133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Prone positioning is a historically underused evidence-based practice for ARDS. Despite increased prone positioning during the COVID-19 pandemic, some patients may remain at risk of nonuse.
Research Question
What is the current evidence-based gap for prone positioning in ARDS, how is use changing over time, and what are patient-level barriers and facilitators to prone positioning?
Study Design and Methods
This retrospective cohort included invasively ventilated adults with ARDS and who met prone positioning criteria from six hospitals. The rate of prone positioning among eligible patients was summarized from January 2018 through December 2021. Segmented Poisson regression was used to describe temporal trends. Logistic regression was used to identify patient-level barriers and facilitators to prone positioning.
Results
Seven hundred ninety-nine patients fulfilled criteria for prone positioning. The mean age was 57 years, 125 patients (15.6%) had COVID-19, mean ICU stay was 19.5 days, and the mortality rate was 50.1%. Prone positioning was used in 297 of 799 patients (37.2%). Prone positioning was increasing before the pandemic with a relative rate (RR) of 1.12 per quarter (95% CI, 1.03-1.22). Prone positioning increased during the pandemic vs before the pandemic (RR, 1.62; 95% CI, 1.02-2.61), but not for patients with nonrespiratory diagnoses causing ARDS (RR, 0.74; 95% CI, 0.22-2.52). Barriers to prone positioning included vasopressor use (OR for withholding prone positioning, 1.15 per 0.1 μm/kg/min norepinephrine equivalent; 95% CI, 1.06-1.26), age (OR, 1.12 per 5 years; 95% CI, 1.03-1.22), and having undergone surgery (OR, 2.41; 95% CI, 1.00-5.81). Facilitators included having COVID-19 (OR for withholding prone positioning, 0.10; 95% CI, 0.04-0.24) or another respiratory illness (OR, 0.42; 95% CI, 0.23-0.79), and receiving neuromuscular blockade (OR, 0.22; 95% CI, 0.13-0.38).
Interpretation
Despite increased prone positioning during the COVID-19 pandemic, an evidence-based gap persists, especially for patients with nonrespiratory causes of ARDS. Multiple barriers and facilitators must be targeted to increase prone positioning.